# Amplia Therapeutics Leadership Shift | Sydney News

Page: https://stenobird.com/podcast/sydney-news-today-2-min-news-the-daily-news-now-7568669/amplia-therapeutics-leadership-shift-sydney-news
Text version: https://stenobird.com/podcast/sydney-news-today-2-min-news-the-daily-news-now-7568669/amplia-therapeutics-leadership-shift-sydney-news.md
Podcast: [Sydney News Today | 2 Min News | The Daily News Now!](https://stenobird.com/podcast/sydney-news-today-2-min-news-the-daily-news-now-7568669)
Published: 2026-06-30T06:18:26+00:00
Episode link: https://api.fastcast.ai/audio/c2ebf147-ee68-410c-92bc-3f145faff367.mp3
Audio file: https://api.fastcast.ai/audio/c2ebf147-ee68-410c-92bc-3f145faff367.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/sydney-news-today-2-min-news-the-daily-news-now-7568669/episodes/amplia-therapeutics-leadership-shift-sydney-news
Duration seconds: 135

## Resource

Amplia Therapeutics is shaking up its leadership with Jane Bell AM stepping in as chairman, timed perfectly with breakthrough clinical data for its drug narmafotinib — showing a 36% response rate and over 11 months median survival in advanced pancreatic cancer patients, without added toxicity. Backed by recent Nature Medicine research validating its FAK-targeting approach, the company is poised for FDA discussions, fast-track and orphan drug designations, and scaling manufacturing — all while exploring applications in ovarian cancer, pulmonary fibrosis, and as a companion therapy for KRAS inhibitors. This isn’t just a boardroom change — it’s the launchpad for turning science into market reality. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/5a2e5d65e4cff479

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/sydney-news-today-2-min-news-the-daily-news-now-7568669/episodes/amplia-therapeutics-leadership-shift-sydney-news/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/sydney-news-today-2-min-news-the-daily-news-now-7568669/amplia-therapeutics-leadership-shift-sydney-news.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.